Outcome of Concurrent Chemoradiotherapy versus Sequential Chemotherapy Followed by Radiotherapy for Limited Stage Small Cell Lung Cancer Treatment

Authors

  • Suriana Sultana Registrar, Dept. of Clinical Oncology, Delta Hospital Limited, Mirpur, Dhaka, Bangladesh
  • Md Yousuf Ali Senior Consultant, Clinical and Radiation Oncology, LABAID Cancer Hospital, Dhaka, Bangladesh
  • Rowshon Ara Begum Professor of Radiation Oncology, National Institute of Cancer Research & Hospital, Mohakhali, Dhaka, Bangladesh
  • Lubna Mariam Associate Professor of Radiation Oncology, National Institute of ENT, Tejgaon, Dhaka, Bangladesh
  • Asma Siddiqua Associate Professor, Department Radiation Oncology, National Institute of Cancer Research & Hospital, Mohakhali, Dhaka, Bangladesh
  • Mosammat Rubina Sultana Assistant Professor of Radiation Oncology, National Institute of Cancer Research & Hospital, Mohakhali, Dhaka, Bangladesh
  • Sarowat Sultana Registrar, Radiation Oncology, National Institute of Cancer Research & Hospital, Mohakhali, Dhaka, Bangladesh

DOI:

https://doi.org/10.3329/jbcps.v43i4.85016

Keywords:

LS-SCLC, concurrent chemoradiotherapy, sequential chemotherapy, RECIST, RTOG, treatment response

Abstract

Background: Limited-stage small cell lung cancer (LS-SCLC) is a highly aggressive malignancy with poor prognosis. Concurrent chemo-radiotherapy (CCRT) is recommended by guidelines, but sequential chemotherapy followed by radiotherapy (SCRT) is often used in settings with resource limitations and afraid of intolerability. This study compares CCRT with SCRT in terms of clinical and radiological response, and treatment-related toxicities.

Methods: This quasi-experimental prospective study included 60 histologically proven LS-SCLC patients at the National Institute of Cancer Research & Hospital, Dhaka, from July 2020 to June 2021. Patients were divided equally into two arms: Arm A received CCRT (60 Gy in 30 fractions via 3DCRT with concurrent EP chemotherapy), while Arm B received SCRT (4 cycles of EP followed by 60 Gy in 30 fractions via 3DCRT). Response evaluation was done after 12 weeks post-treatment by clinical and radiology using RECIST 1.1 criteria and RTOG toxicity grading.

Results: Complete clinical response was higher in Arm A (86.7%) vs Arm B (80.0%). Radiological response was similar (86.7% vs 83.3%). Improvement in symptoms such as dyspnea (100% vs 100%), weight loss (63.3% vs 31.8%, p=0.039), and chest pain (61.5% vs 23.0%, p=0.016) was significantly better in Arm A. Toxicities were manageable; esophagitis (70.0% vs 63.3%) and radiation pneumonitis (43.3% vs 36.7%) were higher in Arm A but not statistically significant.

Conclusion: In this series CCRT demonstrates noninferior clinical outcomes compared to SCRT in LS-SCLC, with comparable response rates and manageable toxicity. It remains a feasible treatment option for limited stage small cell lung cancer treatment.

J Bangladesh Coll Phys Surg 2025; 43: 261-164

Downloads

Download data is not yet available.
Abstract
29
PDF
23

Downloads

Published

2025-10-30

How to Cite

Sultana, S., Ali, M. Y., Begum, R. A., Mariam, L., Siddiqua, A., Sultana, M. R., & Sultana, S. (2025). Outcome of Concurrent Chemoradiotherapy versus Sequential Chemotherapy Followed by Radiotherapy for Limited Stage Small Cell Lung Cancer Treatment. Journal of Bangladesh College of Physicians and Surgeons, 43(4), 261–164. https://doi.org/10.3329/jbcps.v43i4.85016

Issue

Vol. 43 No. 4 (2025)

Section

Original Articles

License

Submission of a manuscript for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted manuscripts become the permanent property of the Journal of Bangladesh College of Physicians and Surgeons and may not be reproduced by any means in whole or in part without the written consent of the publisher.

No part of the materials published in this journal may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher. Reprints of any article in the Journal will be available from the publisher.